
BIOX Stock Forecast & Price Target
BIOX Analyst Ratings
Bulls say
Bioceres Crop Solutions Corp has demonstrated resilience with its crop protection portfolio, particularly benefiting from strong performance outside Argentina, which is expected to enhance overall revenue growth as Argentine farmer demand potentially rebounds. The company remains well-positioned to leverage robust international opportunities, notably for its HB4 wheat revenue in key markets such as the US, Brazil, and Australia, although revenue growth is anticipated to take time as partnerships are established. Furthermore, despite weaker results in Argentina, the steady momentum from bio-protection products and increased adjuvant sales in other regions has helped mitigate the impact of domestic market challenges, reinforcing a positive outlook on the company's diversified revenue streams.
Bears say
Bioceres Crop Solutions Corp has experienced a significant decline in revenues, with a notable decrease in Crop Nutrition and Seed & Integrated products, which fell approximately 34% and 75% year-over-year, respectively. The company’s transition to a licensing-based business model, moving away from direct seed production and sales, has resulted in diminished contributions from its HB4-related sales, further exacerbating revenue losses. Weak demand in Argentina, compounded by pricing pressures and reduced corn acreage, underscores the challenges the company faces in sustaining growth in its primary markets.
This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.
BIOX Analyst Forecast & Price Prediction
Start investing in BIOX
Order type
Buy in
Order amount
Est. shares
0 shares